Midecamycin: International drug information (concise)

For abbreviations, symbols, and age group definitions used in Lexicomp (show table)

International Brand Names

International Brand Names by Country

For country code abbreviations (show table)

(AR) Argentina: Myoxam;
(BE) Belgium: Merced;
(BG) Bulgaria: Macropen;
(BR) Brazil: Mecacin | Midecamin;
(CL) Chile: Miocamin;
(CN) China: Acetylmidecamycin | Medemycin | Mei jia xin | Miocamycin;
(CO) Colombia: Midecamin;
(DO) Dominican Republic: Midecamin | Myoxam;
(EC) Ecuador: Midecamin;
(EE) Estonia: Makropen;
(EG) Egypt: Miocamen;
(ES) Spain: Momicine | Myoxam;
(FR) France: Mosil;
(GR) Greece: Miocacin | Miocamen;
(IT) Italy: Macroral | Midecin | Miocamen | Miokacin;
(JO) Jordan: Miocamen;
(JP) Japan: Miocamycin;
(KE) Kenya: Miocamen;
(KR) Korea, Republic of: Camicin | Midecamycin | Midesin | Miocamycin | Mydec | Yumicacin;
(LB) Lebanon: Miocamen;
(LT) Lithuania: Macropen;
(LU) Luxembourg: Merced;
(LV) Latvia: Macropen;
(MA) Morocco: Miocamen;
(MX) Mexico: Midecamin;
(PK) Pakistan: Miomax;
(PT) Portugal: Miocacin;
(RU) Russian Federation: Macropen;
(SI) Slovenia: Macropen;
(TH) Thailand: Miotin;
(TN) Tunisia: Miocamen;
(UA) Ukraine: Macropen

Index Terms

Pharmacologic Category

Reported Use

Treatment of infections caused by susceptible strains of Staphylococcus, Streptococcus, Streptococcus pneumoniae, and Mycoplasma

Dosage Range

Adults: Oral: 900-1800 mg/day in 2-3 divided doses

Product Availability

Product available in various countries; not currently available in the US

Dosage Forms

Tablet: 600 mg, 900 mg

Topic 10416 Version 51.0